- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hematological Abnormality
Total 15350 results
-
Groupe Hospitalier Pitie-SalpetriereInstitut National de la Santé Et de la Recherche Médicale, FranceCompletedHematological Abnormality | HematotoxicityFrance
-
University Hospital MuensterStudy Chair and Principal Investigator: Univ.-Prof. Dr. Alexander Zarbock; Principal...Recruiting
-
Centre Hospitalier Universitaire de NiceRecruiting
-
Minsk Scientific-Practical Center for Surgery,...Belarusian State Medical UniversityCompletedHematological InfectionBelarus
-
Lagos State UniversityUnknownHaematological AbnormalityNigeria
-
Hikari Dx, Inc.Fujimori Kogyo Co., Ltd.CompletedHealthy | Von Willebrand Diseases | Platelet Dysfunction | Congenital Platelets AbnormalityUnited States, France
-
Guangzhou Blood CenterGuangdong Provincial Hospital of Traditional Chinese Medicine; Sun Yat-sen... and other collaboratorsCompletedBlood Transfusion | Blood Group Antigen Abnormality | Rhesus Isoimmunisation Due to Anti-DChina
-
Instituto BernabeuCompleted
-
Rajiv Gandhi Cancer Institute & Research Center...Completed
-
Nanfang Hospital of Southern Medical UniversityXiangya Hospital of Central South University; Peking University People's Hospital and other collaboratorsUnknownMRD | Risk-directed Therapy | Cytogenetic Abnormality | Molecular AbnormalityChina
-
Assiut UniversityNot yet recruitingVaginal Abnormality
-
Sharp HealthCareCompletedNeurodevelopmental AbnormalityCanada, United States, Poland
-
Peking University People's HospitalSanofiRecruitingHematological MalignancyChina
-
M.D. Anderson Cancer CenterNot yet recruiting
-
Beckman Coulter, Inc.Completed
-
Fate TherapeuticsTerminatedHematological MalignancyUnited States
-
University Hospital, Strasbourg, FranceUnknownHematological MalignancyFrance
-
Universitaire Ziekenhuizen KU LeuvenInstitutul Clinic FundeniCompletedHematological MalignancyBelgium, Romania
-
Henry Ford Health SystemRecruitingHematological MalignancyUnited States
-
SanofiCompletedHematological MalignancyGreece, Spain, Peru, Israel, United States, Argentina, Belgium, Brazil, Chile, Finland, France, Italy, Mexico, Russian Federation, Turkey, Ukraine, United Kingdom
-
University of CopenhagenZealand University HospitalEnrolling by invitationHematological MalignancyDenmark
-
Washington University School of MedicineBarnes-Jewish HospitalTerminatedHematological MalignancyUnited States
-
Institut Paoli-CalmettesCompletedHematological MalignancyFrance
-
Shanxi Bethune HospitalRecruitingHematological MalignancyChina
-
Institut Paoli-CalmettesSanofiNot yet recruiting
-
The Affiliated People's Hospital of Ningbo UniversityRecruitingHematological MalignancyChina
-
University of Missouri-ColumbiaRecruiting
-
Zhejiang UniversityRecruiting
-
Cairo UniversityRecruitingNeurophysiologic AbnormalityEgypt
-
Croma-Pharma GmbHProinnovera GmbHActive, not recruitingLip AbnormalityAustria
-
National Taiwan University HospitalCompleted
-
Astellas Pharma Global Development, Inc.Basilea Pharmaceutica International LtdCompletedHematological MalignancyUnited States
-
Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of MedicineCompletedMyeloid Hematological MalignanciesUnited States
-
Centre Hospitalier Universitaire de BesanconTerminatedHematological Malignancies BFrance
-
Centre Psychothérapique de NancyCentre Hospitalier Régional et Universitaire de NancyRecruiting
-
Spectrum Pharmaceuticals, IncOnxeoCompletedSolid Tumor | Hematological MalignancyUnited States
-
Cairo UniversityUnknown
-
Inova Health Care ServicesRecruitingSolid Tumor | Hematological MalignancyUnited States
-
Institut BergoniéRecruitingSolid Tumor | Hematological MalignancyFrance
-
AdaptimmuneTerminatedSolid and Hematological MalignanciesUnited States, Canada
-
Istituto Clinico HumanitasRecruiting
-
Onward TherapeuticsRecruitingSolid Tumor | Hematological MalignancyFrance
-
Prof. Dr. Thomas LuftRecruitingEndothelial Dysfunction | Hematological NeoplasmGermany
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingRelapsed/Refractory Hematological MalignanciesChina
-
Antengene Therapeutics LimitedBristol-Myers SquibbRecruitingSolid Tumor | Hematological MalignancyAustralia
-
AdaptimmuneRecruitingSolid and Hematological MalignanciesUnited States, Spain, Canada, United Kingdom
-
Kite, A Gilead CompanyEnrolling by invitationSolid and Hematological MalignanciesUnited States, Netherlands, Japan, Australia, France, Israel, Germany, Canada, United Kingdom
-
AstraZenecaParexelCompletedSolid and Hematological MalignanciesGermany
-
Centre Hospitalier Universitaire DijonRecruitingDevelopmental AbnormalityFrance
-
Central Hospital, Nancy, FranceUnknownAnatomic Abnormality